Immunome, Inc.
← Back to IMNM Overview

Immunome, Inc. (IMNM)

Solvency & Capital Structure

Total Debt

$3.7M

Net Debt

-$579M

Immunome, Inc. currently has $3.7M in total debt. Net debt is -$579M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

IMNMQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.000.58-0.58Net Cash0.620.6%
2025-12-310.000.65-0.65Net Cash0.680.6%
2025-09-300.000.27-0.27Net Cash0.301.3%
2025-06-300.000.27-0.26Net Cash0.301.4%
2025-03-310.000.32-0.31Net Cash0.341.4%
2024-12-310.000.22-0.21Net Cash0.242.0%
2024-09-300.000.24-0.24Net Cash0.261.1%
2024-06-300.000.28-0.28Net Cash0.300.9%
2024-03-310.000.31-0.31Net Cash0.320.5%
2023-12-310.000.14-0.14Net Cash0.151.1%
2023-09-300.000.09-0.09Net Cash0.090.4%
2023-06-300.000.04-0.04Net Cash0.041.2%
2023-03-310.000.04-0.04Net Cash0.050.5%
2022-12-310.000.02-0.02Net Cash0.021.2%
2022-09-300.000.03-0.03Net Cash0.030.6%
2022-06-300.000.03-0.03Net Cash0.040.5%
2022-03-310.000.04-0.04Net Cash0.050.4%
2021-12-310.000.05-0.05Net Cash0.060.5%
2021-09-300.000.06-0.06Net Cash0.060.0%
2021-06-300.000.06-0.06Net Cash0.060.1%
2021-03-310.000.04-0.04Net Cash0.041.4%
2020-12-310.000.04-0.04Net Cash0.041.4%
2020-09-300.000.01-0.01Net Cash0.015.5%
2020-06-300.000.01-0.01Net Cash0.016.1%
2020-03-310.000.00-0.00Net Cash0.00
2019-12-310.000.00-0.00Net Cash0.0111.1%
2019-03-310.000.00-0.00Net Cash0.00